Výsledky vyhledávání - "Brigitte Schmied"

Incidence and risk factors for suicide, death due to substance use, and violent/accidental death in people with HIV

Publikováno v: Tusch, E S, Ryom, L, Fursa, O, Peters, L, Østergaard, L, Florence, E, Edwards, S, Hoffmann, C, Sambatakou, H, Reiss, P, Shahar, E, Reikvam, D H, Schmied, B, Paduta, D, Yakovlev, A, Szlávik, J, Ranin, J, Zilmer, K, Uždaviniene, V, Pelchen-Matthews, A, Mocroft, A & Reekie, J 2023, ' Incidence and risk factors for suicide, death due to substance use, and violent/accidental death in people with HIV ', AIDS, vol. 37, no. 1, pp. 161-171 . https://doi.org/10.1097/QAD.0000000000003402

OBJECTIVE: Deaths due to suicide, substance use and violence/accident may reflect similar risk factors and overlap in their classification. This study aimed to investigate incidence and risk factors of mortality among people with HIV (PWH) due to the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::244c8c830db579cf9ca286d0e0fa438b
https://doi.org/10.1097/qad.0000000000003402

Zobrazit plný text záznamu

A Lower CD4 Count Predicts Most Causes of Death except Cardiovascular Deaths. The Austrian HIV Cohort Study

Autor: Gisela Leierer, Armin Rieger, Brigitte Schmied, Mario Sarcletti, Angela Öllinger, Elmar Wallner, Alexander Egle, Manfred Kanatschnig, Alexander Zoufaly, Michele Atzl, Michaela Rappold, Ziad El-Khatib, Bruno Ledergerber, Robert Zangerle, on behalf of the Austrian HIV Cohort Study Group

Publikováno v: International Journal of Environmental Research and Public Health
International Journal of Environmental Research and Public Health; Volume 18; Issue 23; Pages: 12532
International Journal of Environmental Research and Public Health, Vol 18, Iss 12532, p 12532 (2021)

(1) Objective: To investigate changes in mortality rates and predictors of all-cause mortality as well as specific causes of death over time among HIV-positive individuals in the combination antiretroviral therapy (cART) era. (2) Methods: We analyzed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa0159c0d41af2c42fc328771bf37156
https://doi.org/10.5167/uzh-210776

Zobrazit plný text záznamu

Safety of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis: an open-label, single-arm, multicentre, phase 3b trial

Autor: Jihad Slim, Moupali Das, Shuping Jiang, Aimee M. Wilkin, Andrew T. A. Cheng, Eric Cua, Robert C. Kalayjian, Joseph J. Eron, Cheryl McDonald, Anson K Wurapa, Jeffrey L. Stephens, Sophia Majeed, Stephanie Cox, Brigitte Schmied, Devi SenGupta, Jean-Daniel Lelièvre, Mehri S McKellar

Background: Current treatment for HIV-infected individuals with renal failure on haemodialysis frequently requires complex regimens with multiple pills. A daily single-tablet regimen of coformulated elvitegravir, cobicistat, emtricitabine, and tenofo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::343a0378c5ba8bf7143f9cc820c0e26d

Zobrazit plný text záznamu

Variation in antiretroviral treatment coverage and virological suppression among three HIV key populations

Publikováno v: Laut, K G, Shepherd, L, Gottfredsson, M, Sedlacek, D, Knysz, B, Begovac, J, Radoi, R, Schmied, B, Chkhartishvili, N, Florence, E, Ristola, M, Fätkenheuer, G, Mulcahy, F, Schmid, P, Kuzovatova, E, Paduta, D, Smidt, J, Domingo, P, Szlávik, J, Lundgren, J, Mocroft, A, Kirk, O & EuroSIDA Study Group 2018, ' Variation in antiretroviral treatment coverage and virological suppression among three HIV key populations ', AIDS (London, England), vol. 32, no. 18, pp. 2807-2819 . https://doi.org/10.1097/QAD.0000000000002035

Objectives: We assessed differences in antiretroviral treatment (ART) coverage and virological suppression across three HIV key populations, as defined by self-reported HIV transmission category: sex between men, injection drug use (IDU) and heterose

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9fe07dda086d59b27922bbc33c005c7
https://pure.au.dk/portal/da/publications/variation-in-antiretroviral-treatment-coverage-and-virological-suppression-among-three-hiv-key-populations(9ba56ebe-ab90-47d8-9563-5270ccd7d5db).html

Zobrazit plný text záznamu

HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension

Autor: Brigitte Schmied, Markus Peck-Radosavljevic, Thomas Reiberger, Arnulf Ferlitsch, Alfred Gangl, Armin Rieger, F Breitenecker, Wolfgang Sieghart, A. Kreil

Publikováno v: Journal of Viral Hepatitis. 17:400-409

Patients co-infected with the human immunodeficiency virus (HIV) and the hepatitis C virus (HCV) are fraught with a rapid fibrosis progression rate and with complications of portal hypertension (PHT) We aimed to assess the influence of immune functio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::350ac6ab1d3b96116b697d463fec5672
https://doi.org/10.1111/j.1365-2893.2009.01197.x

Zobrazit plný text záznamu

German-austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn - update 2008

Autor: Matthias Beichert, Annette Haberl, Ulrich Marcus, Brigitte Schmied, Thomas Grubert, Andrea Gingelmaier, Bernd Buchholz

Publikováno v: European Journal of Medical Research, Vol 14, Iss 11, p 461 (2009)
European Journal of Medical Research

German-Austrian recommendations for HIV1-therapy in pregnancy - Update 2008 Bernd Buchholz (University Medical Centre Mannheim, Pediatric Clinic), Matthias Beichert (Mannheim, Gynecology and Obstetrics Practice), Ulrich Marcus (Robert Koch Institute,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50ea8763bb63a1c97e2b6caaa24ad9ff
https://doi.org/10.1186/2047-783x-14-11-461

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání